Thu, May Soe
Pongpirul, Krit
Vongsaisuwon, Mawin
Vinayanuwattikun, Chanida
Banchuen, Kamonwan
Ondee, Thunnicha
Payungporn, Sunchai
Phutrakool, Phanupong
Nootim, Preecha
Chariyavilaskul, Pajaree
Cherdchom, Sarocha
Wanaratna, Kulthanit
Hirankarn, Nattiya
Funding for this research was provided by:
Ministry of Public Health (KPT.14/2566, KPT.14/2566, KPT.14/2566, KPT.14/2566, KPT.14/2566, KPT.14/2566, KPT.14/2566, KPT.14/2566, KPT.14/2566, KPT.14/2566, KPT.14/2566, KPT.14/2566, KPT.14/2566)
Article History
Received: 8 December 2023
Accepted: 4 March 2024
First Online: 23 March 2024
Declarations
:
: The trial was approved by the Institutional Review Board of the Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand (COA No. 1713/2022; IRB No.0548/65) on 20th December 2022 in compliance with the international guidelines for human research protection as Declaration of Helsinki, The Belmont Report, CIOMS Guideline and International Conference on Harmonization in Good Clinical Practice (ICH-GCP). The participants provide written informed consent.
: Not applicable.
: The authors declare no competing interests.